Search research articles
Contact Us
Filters
Showing results (381-390 of 405) with videos related to
Page
of 41
Sort By:
Nature Communications
|
May 7, 2020
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
Mausita Karmakar, Martin Minns, Elyse N Greenberg, et al.
The Journal of Infectious Diseases
|
November 15, 2014
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine
Marshall J Glesby, Wendy Watson, Cynthia Brinson, et al.
The Journal of Gene Medicine
|
January 17, 2013
Patient monitoring and follow-up in lentiviral clinical trials
Gerard J McGarrity, Gloria Hoyah, April Winemiller, et al.
Regulatory Peptides
|
July 28, 2009
High-salt intake primes the rat kidney to respond to a subthreshold uroguanylin dose during ex vivo renal perfusion
Manassés C Fonteles, A Havt, Rodrigo B Prata, et al.
The Journal of Infectious Diseases
|
September 17, 2011
Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults
Jeffrey S Kennedy, Marc Gurwith, Cornelia L Dekker, et al.
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group
J Plouffe, D B Schwartz, A Kolokathis, et al.
Plos One
|
November 12, 2015
Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
Richard N Greenberg, Maria Yadira Hurley, Dinh V Dinh, et al.
Mycoses
|
December 10, 2021
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study
George R Thompson, Julia Garcia-Diaz, Marisa H Miceli, et al.
Plos One
|
June 22, 2016
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects
Richard N Greenberg, Christine M Hay, Jack T Stapleton, et al.
Kidney International
|
December 17, 2003
Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor
Stephen L Carrithers, Cobern E Ott, Michael J Hill, et al.
Page
of 41
Search research articles
Search
Showing results (381-390 of 405) with videos related to
Sort By:
Page
of 41
Nature Communications
|
May 7, 2020
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
Mausita Karmakar, Martin Minns, Elyse N Greenberg, et al.
The Journal of Infectious Diseases
|
November 15, 2014
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine
Marshall J Glesby, Wendy Watson, Cynthia Brinson, et al.
The Journal of Gene Medicine
|
January 17, 2013
Patient monitoring and follow-up in lentiviral clinical trials
Gerard J McGarrity, Gloria Hoyah, April Winemiller, et al.
Regulatory Peptides
|
July 28, 2009
High-salt intake primes the rat kidney to respond to a subthreshold uroguanylin dose during ex vivo renal perfusion
Manassés C Fonteles, A Havt, Rodrigo B Prata, et al.
The Journal of Infectious Diseases
|
September 17, 2011
Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults
Jeffrey S Kennedy, Marc Gurwith, Cornelia L Dekker, et al.
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group
J Plouffe, D B Schwartz, A Kolokathis, et al.
Plos One
|
November 12, 2015
Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
Richard N Greenberg, Maria Yadira Hurley, Dinh V Dinh, et al.
Mycoses
|
December 10, 2021
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study
George R Thompson, Julia Garcia-Diaz, Marisa H Miceli, et al.
Plos One
|
June 22, 2016
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects
Richard N Greenberg, Christine M Hay, Jack T Stapleton, et al.
Kidney International
|
December 17, 2003
Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor
Stephen L Carrithers, Cobern E Ott, Michael J Hill, et al.
Page
of 41